NASDAQ: SRDX

Surmodics Inc Stock Forecast, Predictions & Price Target

The consensus among 2 Wall Street analysts covering (NASDAQ: SRDX) stock is to Buy SRDX stock.

Out of 2 analysts, 0 (0%) are recommending SRDX as a Strong Buy, 2 (100%) are recommending SRDX as a Buy, 0 (0%) are recommending SRDX as a Hold, 0 (0%) are recommending SRDX as a Sell, and 0 (0%) are recommending SRDX as a Strong Sell.

If you're new to stock investing, here's how to buy Surmodics stock.

(NASDAQ: SRDX) Surmodics's forecast annual revenue growth rate of 2.69% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.23%.

Surmodics's revenue in 2024 is $138,203,000.On average, 2 Wall Street analysts forecast SRDX's revenue for 2024 to be $1,716,363,340, with the lowest SRDX revenue forecast at $1,716,149,800, and the highest SRDX revenue forecast at $1,716,576,880. On average, 2 Wall Street analysts forecast SRDX's revenue for 2025 to be $2,041,655,940, with the lowest SRDX revenue forecast at $2,041,300,040, and the highest SRDX revenue forecast at $2,042,011,840.

In 2026, SRDX is forecast to generate $2,466,102,280 in revenue, with the lowest revenue forecast at $2,463,824,520 and the highest revenue forecast at $2,468,380,040.

According to 2 Wall Street analysts that have issued a 1 year SRDX price target, the average SRDX price target is $59.00, with the highest SRDX stock price forecast at $71.00 and the lowest SRDX stock price forecast at $47.00.

On average, Wall Street analysts predict that Surmodics's share price could reach $59.00 by Apr 10, 2025. The average Surmodics stock price prediction forecasts a potential upside of 126.31% from the current SRDX share price of $26.07.

(NASDAQ: SRDX) forecast ROE is N/A, which is considered weak.